Board certified in pediatrics and pediatric hematology/oncology, Dr. Nugent specializes in all aspects of bleeding and clotting disorders, hematology, bone marrow failure, anemia, and immune disorders. Dr. Nugent founded CIBD with the goal of serving children and adults with genetic blood disorders, and their families, with comprehensive care tailored just for them. In 2005, she was named the National Hemophilia Foundation Physician of the Year, and later one of the Best Doctors in America in 2007-2008. She was also named Physician of the Year in Orange County. More recently in 2011, she received the Physician Circle of Care Award from Cal-Optima. Dr. Nugent serves as a Clinical Professor at the University of California, Irvine (UCI). Among her peers, Dr. Nugent is the chair of review subcommittees for the National Heart, Lung, and Blood Institute/National Institutes of Health, and head of program projects for the hematology committees of the American Society of Hematology and International Society on Thrombosis and Hemostasis. Dr. Nugent received her fellowship training at Children’s Hospital Medical Center in Seattle and Fred Hutchinson Cancer Research Center. Upon graduating from the University of California, Los Angeles, School of Medicine, she completed her residency and internship at Denver Affiliated Hospitals in Colorado. Dr. Nugent speaks Spanish.
Mary E. Brown, MemberPresident & CEO, Sickle Cell Disease Foundation of California
In dedicating her career to education and research of sickle cell disease and related disorders, Ms. Brown has served a variety of healthcare-related non-profits. Currently, she is the Board Chair for the Community Health Charities of California, and also a board member of the Sickle Cell Disease Association of America, and Painted Turtle Camp, a summer camp for children with life-threatening illnesses. She also lends her leadership skills serving as the Director of Camp Crescent Moon. In 2012, Ms. Brown was recognized for her work by the American Camp Association when she received the Legacy Award for the ACA Southern California/Hawaii section. Ms. Brown is a graduate of California State University, Los Angeles where she earned her B.A. in education and psychology.
Amit Soni, M.D., Board Vice PresidentPediatric Hematology/Oncology, CHOC Children’s Specialists, Division of Hematology
Board certified in pediatrics and pediatric hematology/oncology, Dr. Soni’s clinical and research focus is hemophilia and other bleeding disorders, especially as they relate to teens. In his pursuit to finding innovative ways to connect with teen patients with hemophilia, Dr. Soni worked on a grant for special strategic communications training from the Robert Wood Johnson Foundation to create interactive media aimed at connecting with teens with hemophilia. The goal is to provide teens with information about their disorder, so that they can take control of their health, and live productive lives as adults. More recently, he received the distinguished international Bayer Hemophilia Clinical Training Award. A member of the CIBD physician team, Dr. Soni has medical staff privileges at CHOC Children’s Hospital in Orange, CA. Dr. Soni completed medical school at Saint George’s University in Grenada, West Indies, completed his residency at the University of Medicine and Dentistry of New Jersey, and his fellowship at Children’s Hospital of Orange County where today he is a hemostasis/thrombosis clinical research fellow director. He earned certification in clinical trials and product development from UCI’s graduate program.
Barry Staton, MBA, Board Treasurer, Audit Committee ChairChief Financial Officer, Central California Alliance for Health
Before being appointed as the Chief Financial Officer for the Central California Alliance for Health, Mr. Staton served as the Director of Financial Analysis at Cal-Optima, a county-organized health system that administers health insurance in Orange County, CA. While there, he was responsible for actuarial services, biostatistics, cost and utilization trending, return on investment analyses, and decision support. He brings over 22 years of healthcare experience, specifically with health plan, hospital, and medical group operations to CIBD’s board. Mr. Staton earned his B.A. and MBA from the University of Southern California.
Kathie Birschbach, Board SecretaryResearch Administrator, Hematology Research Team, Children’s Hospital of Orange County
Beginning her career at the State of Wisconsin’s Division of Vocational Rehabilitation was the spark that led Ms. Birschbach to a lifetime interest of providing and improving services for people with chronic illnesses. Today, working in the hematology division at Children’s Hospital of Orange County, she is the Research Administrator for Dr. Nugent’s hematology research team. Ms. Birschbach has been instrumental in providing factor therapy to patients with rare bleeding disorders nationwide, particularly those with Factor XIII deficiency. Her tireless efforts with Dr. Nugent resulted in a new FDA-approved Factor XIII concentrate. Ms. Birschbach plays a vital role in fellowship training—preparing future hematologists—and is also part of the administrative staff supporting Region IX.
Randall Curtis, B.S., MBA, MemberChief Information Security Officer, State of California Department of Industrial Relations
Living with severe hemophilia, Randall Curtis has translated his condition into a benefit to others. His real-life experiences have led him to develop hemophilia database systems, collaborate with the Universal Data Collection Working Group at the CDC in Atlanta, and serve 25 years at the Genetic Disease Branch of the California Department of Health Services. Mr. Curtis holds a B.S. in Genetics, an M.B.A. in Computer Information Systems, and is also a certified Project Management Professional (PMP). He has presented data at national and international meetings, and is currently working on the Hemophilia Utilization Group Study (HUGS
Bertil Glader, M.D., Ph.D., MemberDirector, RBS Laboratory, Stanford University
Shortly after completing his internship in Pediatrics at Stanford University, Dr. Glader served in the U.S. Army as a research hematologist at Walter Reed Army Institute of Research. His medical career continued on the east coast when he became a fellow at Children’s Hospital in Boston and Harvard Medical School. Later, he returned to Stanford as the Chief of the Pediatric Hematology/Oncology Division, where today he is a Professor of Pediatrics and Pathology. Dr. Glader’s research interests include genetic hematologic problems, in particular bleeding and bone marrow failure disorders. Currently, he serves as the medical director of the RBS Special Studies Laboratory at Stanford, in addition to being the Clinical Coordinator for hemophilia gene therapy studies. Co-editor of Wintrobe’s Textbook of Clinical Hematology, Dr. Glader, earned his Ph.D. in physiology from the University of Illinois, and his medical degree from Northwestern University.
Derek Robertson, JD, MBA, MemberVice President, Regulatory Affairs, Apogenics, Inc.
As a healthcare attorney and consultant, Mr. Robertson brings expertise in government pricing programs, specifically the Public Health Service Section 340B Drug Pricing Discount Program, also known as the 340B Program. His background encompasses Medicare and Medicaid reimbursement, and the federal Medicaid Drug Rebate Program. In his role as a vice president of regulatory affairs for a consulting firm, he advises his clients on how to stay in compliance with various federal laws and regulations, including anti-kickback laws and guidelines for federal drug pricing discount programs. He has worked extensively with hospitals and universities on federal grants management, program income calculation, and reporting. He presents nationally at conferences about government pricing programs, specialty pharmacy trends, and conflicts of interest in healthcare. Mr. Robertson holds an MBA from City University of New York, Baruch College, and Doctor of Jurisprudence from the University of Houston Law Center.